CVS Health (CVS) Will Likely Pursue More M&A After Signify Health (SGFY) - Analyst
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Companies with NDRs 9/07
September 7, 2022 7:14 AM EDTCompanies with non-deal roadshows or company visits/marketing with sell-side today:
CVS Health (NYSE: CVS) Mizuho NDR San FranciscoSherwin-Williams (NYSE: SHW) Mizuho NDR New YorkSilgan Holdings (NYSE: SLGN) KeyBanc NDR BostonFor a daily calendar of NDRs, conferences and other events please visit our calendar page.
... MoreCVS Health's (CVS) Signify Health Deal to 'Bolster Health Services Business Growth' - Mizuho
September 6, 2022 12:35 PM EDTMizuho Securities analyst Ann Hynes reiterated a Buy rating and $120.00 price target on CVS Health (NYSE: CVS), saying the Signify Health deal bolsters health services business growth.
The analyst commented, "We believe this deal will accelerate CVS's value-based care initiatives through SGFY's proprietary platforms. As a reminder, at its investor day last December, CVS... More
